title: Letter: infliximab vs. adalimumab in treating ambulatory perianal fistulising Crohn's disease.
authors.affiliation: Gastroenterology Service, ASL BAT, Andria, BT, Italy. antotursi@tiscali.it.
authors.forename: A
authors.initials: A
authors.lastname: Tursi
authors.forename: W
authors.initials: W
authors.lastname: Elisei
authors.forename: M
authors.initials: M
authors.lastname: Picchio
authors.forename: C
authors.initials: C
authors.lastname: Zampaletta
authors.forename: R
authors.initials: R
authors.lastname: Faggiani
authors.forename: G
authors.initials: G
authors.lastname: Brandimarte
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized